We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Other cookies are those that are being identified and have not been classified into any category as yet.
Gold(I)-catalyzed transformations have been studied in the last two decades for the construction of molecular complexity. This Doctoral Thesis has principally focused on expanding the knowledge in asymmetric gold(I) catalysis and the development of new gold(I) catalysts.
First, new families of gold(I) complexes have been synthesized based on previous dialkylbiphenyl-phosphine ligands bearing a C2-symmetric 2,5-disubstituted pyrrolidines developed by our group.
– Removing one phenyl of the biphenyl scaffold approaching the chiral information to the gold(I) metal has proved to give good enantioselectivity results. For example, in the atroposelective cyclization reaction of sulfonamides.
– Substituting the phosphine by an N-heterocyclic carbene afforded chiral NHC gold(I) complexes and their reactivity and enantioselectivity were compared to the ones provided by the model ligand.
– Preparing sterically hindered ligands with one, two or three chiral 2,5-disubstituted pyrrolidines was achieved. They were tested in different transformations giving in general high yields, but not showing good enantioselectivities.
Other chiral gold(I) complexes have been prepared bearing one or two amino acids to take advantage of their natural chirality to induce enantioselectivity. However, the possible racemization, the asymmetry of the ligands (when only one amino acid is present) and/or the free rotation of the bonds of the amino acids have obstructed their enantioinduction.
Other area of study has been the development of a gold(I) complex active in senescent cells. The complex with β-galactoses would be inactive against of a prodrug or fluorophore under biological conditions but taking advantage of the high presence of associated β-galactosidase it will be active due to the cleavage of the galactoses releasing the active gold(I) complex. To this end, there have been developed two NHC-gold(I) complexes, with and without β-galactoses. These catalysts were tested under biologically conditions in a hydroarylation reaction producing a fluorescent coumarin. Modest different reactivities for both complexes have been observed under several reaction conditions.
If you would like to follow the ceremony on Zoom, please register here.
Join our team to work with renowned researchers, tackle groundbreaking
projects and contribute to meaningful scientific advancements